Accretion Pharmaceuticals IPO subscription status Day 1: The initial public offering (IPO) of Accretion Pharmaceuticals ...

The ex-date for a demerger is the date on which shares of the parent company start trading without the right to receive ...

Indian Embassy in Beijing had warned Chinese media of not spreading unverified information related to Operation Sindoor ...

Nothing CEO Carl Pei said that with Phone 3, the company is "going all in" on "premium materials, major performance upgrades, ...

The up move in the GSK Pharma share price came after the company posted a healthy March quarter of financial year 2025 ...

Metal stocks shined in trade and gained up to 5 per cent on Wednesday, May 14, 2025. The Nifty Metal index, which tracks the ...

India, the world's second-largest importer of refined copper, relies on imports to address shortfalls and meet robust demand ...

The portion booked for retail investors is subscribed 57 per cent, and the NII quota is subscribed 63 per cent ...

The 90-day temporary easing of US tariffs on China has introduced a high level of uncertainty, with the Chinese auto sector ...

Metal stocks were trading in green, with the BSE Metal index increasing 757.13 points or 2.54% at 30592.09 at 09:46 IST.

Puravankara announced that its board will meet on 16 May 2025, to consider raising Rs 300 crore through the issuance of non-convertible debentures (NCDs) on a private placement basis.

The audience that is there on quick commerce is more disposed to experiment because they have more disposable incomes, said ...